Novartis to sell long-held stake in Roche for nearly $21B
Bio Pharma Dive
NOVEMBER 4, 2021
Novartis, which paid around $5 billion for its shares two decades ago, says it will gain about $14 billion from its sale and use the proceeds to further its current strategy.
Let's personalize your content